Definitive Guide to Global Transparency Regulations for the Life Sciences
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.
A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.
Can medical-grade wearables provide efficient, patient-friendly, and cost-effective solutions in an ever-changing healthcare environment?
Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.